Sulfasalazine (International)
Note: In some countries, this medicine may only be approved for veterinary use.
In the US, Sulfasalazine (sulfasalazine systemic) is a member of the following drug classes: 5-aminosalicylates, antirheumatics and is used to treat Alopecia, Crohn's Disease, Crohn's Disease - Acute, Crohn's Disease - Maintenance, Inflammatory Bowel Disease, Juvenile Rheumatoid Arthritis, Lymphocytic Colitis, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ulcerative Colitis - Active, Ulcerative Colitis - Maintenance and Uveitis.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
A07EC01
CAS registry number (Chemical Abstracts Service)
0000599-79-1
Chemical Formula
C18-H14-N4-O5-S
Molecular Weight
398
Therapeutic Categories
Disease-modifying antirheumatic drug, DMARD
Antibacterial: Sulfonamide
Chemical Name
Benzoic acid, 2-hydroxy-5-[[4-[(2-pyridinylamino)sulfonyl]phenyl]azo]-
Foreign Names
- Sulfasalazinum (Latin)
- Sulfasalazin (German)
- Sulfasalazine (French)
- Sulfasalazina (Spanish)
Generic Names
- Salazosulfapyridine (OS: JAN)
- Sulfasalazina (OS: DCIT)
- Sulfasalazine (OS: USAN, BAN, DCF)
- Azopyrin (IS)
- Salicylazosulfapyridine (IS)
- Salazosulfapyridine (PH: JP XVII)
- Sulfasalazin (PH: Ph. Eur. 9.2)
- Sulfasalazine (PH: BP 2018, Ph. Eur. 9.2, Ph. Int. 7, USP 41)
- Sulfasalazinum (PH: Ph. Eur. 9.2, Ph. Int. 7)
Brand Names
- Azulfidina
Pfizer, Mexico - Azulfidine
Laboratorio Pfizer de Chile, Chile; Pfizer, Argentina; Pfizer, Uruguay; Pfizer, Venezuela; Pharmacia, Germany; Pharmacia & Upjohn, United States - Azulfidine EN
Pfizer Japan, Japan - Azulfidine RA
Pfizer, Germany; Pharmacia, Germany - Azulfin
Apsen, Brazil - Bomecon
Fu Seng, Taiwan - Chang Jian Ning
Qiangji Pharmaceutical Factory, China - Colo-Pleon
Sanofi-Aventis Deutschland, Germany - Colopyrin
Kahira, Egypt - Colosalazine EC
Acdima, Egypt - Disalazin
AC Farma, Peru - Eurozina-RE
Eurolab, Chile - Falazine
Indunidas, Ecuador - Flogostop
Ivax, Argentina - Getsazine
Unique Life Sciences, India - Iwata
Cadila, India - Lazafin
Novell Pharmaceutical, Indonesia - Pleon RA
Sanofi, Germany - PMS-Sulfasalazine
Pharmascience, Canada; Pharmascience, Singapore - PMS-Sulfasalazine EC
Pharmascience, Canada - Pyralin EN
Pfizer, Australia - Reumazin
Aristopharma, Bangladesh - Saaz
IPCA, India - Saaz-DS
IPCA, India - Salasopyrine
Pharmacia Upjohn, Oman - Salazar
Cadila HC, India - Salazidin
AC Helcor, Romania - Salazine
Opsonin, Bangladesh; Sriprasit Pharma, Thailand; Taiwan Biotech, Taiwan - Salazobactin 500 mg voor honden [veterinary use]
AST, Netherlands - Salazodin
Haymann, Uruguay - Salazopirina
Jaba, Portugal - Salazopyrin
Kemwell AB, Israel; Pfizer, Australia; Pfizer, Bosnia & Herzegowina; Pfizer, Canada; Pfizer, Denmark; Pfizer, Finland; Pfizer, United Kingdom; Pfizer, Ireland; Pfizer, New Zealand; Pfizer, Poland; Pfizer, Sweden; Pfizer, Turkey; Pfizer, South Africa; Pfizer ApS, Iceland; Pfizer Consumer Healthcare, Malta; Pfizer Japan, Japan; Pfizer Pharmaceuticals Ltd, China; Pharmacia & Upjohn, Kuwait; Wallace, India; Pfizer, Lithuania - Salazopyrin 500 mg
Pfizer, Austria - Salazopyrin 500mg
Pfizer PFE, Switzerland - Salazopyrin EN
Kemwell AB, Israel; Pfizer, Australia; Pfizer, Czech Republic; Pfizer, United Kingdom; Pfizer, Ireland; Pfizer, Malaysia; Pfizer, New Zealand; Pfizer, Sweden; Pfizer, Singapore; Pfizer, Taiwan; Pfizer ApS, Iceland; Phrmcia, Egypt; Kemwell, Serbia; Pfizer, Canada; Pfizer, Estonia; Pfizer, Finland; Pfizer, Hong Kong; Pfizer, Croatia (Hrvatska); Pfizer, Norway; Pfizer, Thailand - Salazopyrin EN 500 mg
Pfizer, Hungary - Salazopyrin EN 500mg
Pfizer PFE, Switzerland - Salazopyrina
Pfizer, Spain - Salazopyrine
Pfizer, Belgium; Pfizer, France; Pfizer, Netherlands; Pfizer, Tunisia; Pharmacia, Lebanon - Salazopyrine E.C.
Pfizer, Belgium; Pfizer, Netherlands - Salazopyrine E.C. 500mg
Pfizer, Luxembourg - Salazopyrin-EN
Pfizer Italia, Italy - Salazosulfapyridine
Choseido Pharmaceutical, Japan; Daiko Seiyaku, Japan; Nichi-Iko Pharmaceutical, Japan; Shiono Kemikaru, Japan; Takeda Teva Pharma, Japan - Salazosulfapyridine [veterinary use]
Kombivet, Netherlands - Salivon
Pharos, Indonesia - Salopyrine
Adelco, Greece - Sarazopyrin
Ilsung, South Korea - Saridine-E
Atlantic Lab, Hong Kong; Atlantic Lab, Thailand - Sazo
Wallace, India - Sulazine EC
Chatfield Pharmaceuticals, Cyprus - Sulcolon
Bernofarm, Indonesia - Sulfacol
Drug International, Bangladesh - Sulfasalazin
Krka, Georgia - Sulfasalazin EN
Krka, Bosnia & Herzegowina; Krka, Bulgaria; Krka, Romania - Sulfasalazin EN Krka
Krka, Poland - Sulfasalazin HEXAL
Hexal, Germany; Hexal, Denmark - Sulfasalazin K
Krka, Czech Republic - Sulfasalazin K-EN
Krka, Czech Republic - Sulfasalazin Krka
Krka, Latvia; Krka, Macedonia; Krka, Poland - Sulfasalazin medac
Medac, Denmark; Medac, Sweden; medac, Germany - Sulfasalazina
Recipe, Colombia - Sulfasalazina Pharma Arte
Pharma Arte, Paraguay - Sulfasalazine
P & D, Malta; Rosemont Pharmaceuticals, United Kingdom; Vintage, United States; Watson Pharmaceutical, United States - Sulfasalazine Krka
Krka, Lithuania - Sulfasalazine Mylan
Mylan, Netherlands - Sulfasalazine Sandoz
Sandoz, Netherlands - Sulfasalazine Teva
Teva Pharma, Netherlands - Sulfasalazine-En
Krka, Slovakia - Sulfasalazin-EN
Krka, Georgia - Sulfasalazin-Heyl
Heyl, Germany; Heyl, Malta - SulfasalazinKrka EN
Krka, Croatia (Hrvatska) - Sulfasalazino 500 mg Endokrininiai preparatai
Endokrininiai preparatai, Lithuania - Sulfitis
Fahrenheit, Indonesia - Weiliufen
Sunve, China - Zopyrin
Hanlim, South Korea; Hanlim Pharm, Hong Kong
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.